Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 54.62% is in line with its 5-year average of 53.03%, near the high end of its 5-year range (47.70%–57.06%).
0.79% above its 12-month average of 54.19%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-05-31): 57.06%.
GROSS MARGIN
54.62%
GROSS MARGIN AVG TTM
54.19%
GROSS MARGIN AVG 3Y
52.99%
GROSS MARGIN AVG 5Y
53.03%
GROSS MARGIN AVG 10Y
52.84%
GROSS MARGIN AVG 15Y
52.34%
GROSS MARGIN AVG 20Y
53.87%
CURRENT VS TTM AVG
+0.79%
CURRENT VS 3Y AVG
+3.08%
CURRENT VS 5Y AVG
+3.00%
CURRENT VS 10Y AVG
+3.37%
CURRENT VS 15Y AVG
+4.36%
CURRENT VS 20Y AVG
+1.38%
SECTOR MEDIAN · HEALTHCARE
39.94%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
+36.76%
vs the sector median at left
AngioDynamics, Inc.
Market Cap
$610.27M
Gross Margin
54.62%
TTM Avg
54.19%
3Y Avg
52.99%
5Y Avg
53.03%
Market Cap
$601.66M
Gross Margin
99.76%
TTM Avg
98.92%
3Y Avg
99.03%
5Y Avg
96.38%
Market Cap
$596.86M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$621.32M
Gross Margin
-58.05%
TTM Avg
20.98%
3Y Avg
10.49%
5Y Avg
14.13%
Market Cap
$593.29M
Gross Margin
35.58%
TTM Avg
39.19%
3Y Avg
43.45%
5Y Avg
55.13%
Market Cap
$588.70M
Gross Margin
73.65%
TTM Avg
72.81%
3Y Avg
73.64%
5Y Avg
74.48%
Market Cap
$577.15M
Gross Margin
67.04%
TTM Avg
65.22%
3Y Avg
62.15%
5Y Avg
65.14%
Market Cap
$647.51M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $610.27M | 54.62% | 54.19% | 52.99% | 53.03% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $601.66M | 99.76% | 98.92% | 99.03% | 96.38% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $596.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Prime Medicine, Inc. (PRME)vs › | $621.32M | -58.05% | 20.98% | 10.49% | 14.13% |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.29M | 35.58% | 39.19% | 43.45% | 55.13% |
| OrthoPediatrics Corp. (KIDS)vs › | $588.70M | 73.65% | 72.81% | 73.64% | 74.48% |
| Climb Bio, Inc. (CLYM)vs › | $641.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $577.15M | 67.04% | 65.22% | 62.15% | 65.14% |
| Aura Biosciences, Inc. (AURA)vs › | $647.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| OmniAb, Inc. (OABI)vs › | $645.85M | -18.17% | 40.91% | 70.46% | 80.30% |
Gross Margin
54.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-05-31 | 57.06% |
| 2026-02-28 | 52.89% |
| 2025-11-30 | 53.05% |
| 2025-08-31 | 55.29% |
| 2025-05-31 | 52.67% |
| 2025-02-28 | 53.97% |
| 2024-11-30 | 54.78% |
| 2024-08-31 | 54.41% |
| 2024-05-31 | 54.26% |
| 2024-02-29 | 47.70% |
| 2023-11-30 | 50.92% |
| 2023-08-31 | 50.92% |
| 2023-05-31 | 50.90% |
| 2023-02-28 | 50.18% |
| 2022-11-30 | 52.77% |
| 2022-08-31 | 51.88% |
| 2022-05-31 | 53.40% |
| 2022-02-28 | 52.16% |
| 2021-11-30 | 51.81% |
| 2021-08-31 | 52.15% |
| 2021-05-31 | 55.07% |
| 2021-02-28 | 54.13% |
| 2020-11-30 | 55.21% |
| 2020-08-31 | 50.93% |
| 2020-05-31 | 51.79% |
| 2020-02-29 | 57.75% |
| 2019-11-30 | 59.35% |
| 2019-08-31 | 57.87% |
| 2019-05-31 | 16.34% |
| 2019-02-28 | 44.20% |
| 2018-11-30 | 44.32% |
| 2018-08-31 | 42.13% |
| 2018-05-31 | 53.75% |
| 2018-02-28 | 54.20% |
| 2017-11-30 | 49.28% |
| 2017-08-31 | 48.27% |
| 2017-05-31 | 48.71% |
| 2017-02-28 | 51.16% |
| 2016-11-30 | 50.56% |
| 2016-08-31 | 51.12% |
| 2016-05-31 | 44.79% |
| 2016-02-29 | 49.82% |
| 2015-11-30 | 51.42% |
| 2015-08-31 | 51.82% |
| 2015-05-31 | 50.12% |
| 2015-02-28 | 43.71% |
| 2014-11-30 | 51.72% |
| 2014-08-31 | 52.47% |
| 2014-05-31 | 49.77% |
| 2014-02-28 | 50.79% |
| 2013-11-30 | 50.65% |
| 2013-08-31 | 50.95% |
| 2013-05-31 | 49.14% |
| 2013-02-28 | 50.51% |
| 2012-11-30 | 50.67% |
| 2012-08-31 | 47.31% |
| 2012-05-31 | 54.03% |
| 2012-02-29 | 57.04% |
| 2011-11-30 | 57.20% |
| 2011-08-31 | 59.06% |
| 2011-05-31 | 57.46% |
| 2011-02-28 | 58.05% |
| 2010-11-30 | 59.09% |
| 2010-08-31 | 58.28% |
| 2010-05-31 | 57.99% |
| 2010-02-28 | 57.99% |
| 2009-11-30 | 59.12% |
| 2009-08-31 | 60.15% |
| 2009-05-31 | 61.90% |
| 2009-02-28 | 61.12% |
| 2008-11-30 | 61.27% |
| 2008-08-31 | 61.95% |
| 2008-05-31 | 62.70% |
| 2008-02-29 | 62.17% |
| 2007-11-30 | 61.34% |
| 2007-08-31 | 59.96% |
| 2007-05-31 | 58.86% |
| 2007-03-03 | 59.65% |
| 2006-12-02 | 58.45% |
| 2006-09-02 | 58.85% |
| 2006-06-03 | 57.68% |
| 2006-02-25 | 58.37% |
| 2005-11-26 | 57.98% |
| 2005-08-27 | 58.17% |
| 2005-05-28 | 56.29% |
| 2005-02-26 | 55.44% |
| 2004-11-27 | 55.99% |
| 2004-08-28 | 53.36% |
| 2004-05-29 | 53.26% |
| 2004-02-29 | 57.14% |
| 2003-05-31 | 51.92% |
| 2003-02-28 | 0.00% |
